Stage IV breast cancer: a population-based study about prognostic factors according to HER2 and HR status.
about
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patientsBreast cancer subtype of French women is not influenced by socioeconomic status: A population-based-study.Trastuzumab and survival of patients with metastatic breast cancer.Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients.The Difference in Prognostic Outcomes Between De Novo Stage IV and Recurrent Metastatic Patients with Hormone Receptor-positive, HER2-negative Breast Cancer.Benefit of everolimus as a monotherapy for a refractory breast cancer patient bearing multiple genetic mutations in the PI3K/AKT/mTOR signaling pathway
P2860
Stage IV breast cancer: a population-based study about prognostic factors according to HER2 and HR status.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Stage IV breast cancer: a popu ...... cording to HER2 and HR status.
@en
type
label
Stage IV breast cancer: a popu ...... cording to HER2 and HR status.
@en
prefLabel
Stage IV breast cancer: a popu ...... cording to HER2 and HR status.
@en
P2093
P2860
P356
P1476
Stage IV breast cancer: a popu ...... cording to HER2 and HR status.
@en
P2093
A Darut-Jouve
F Beltjens
I Desmoulins
T Ponnelle
P2860
P304
P356
10.1111/ECC.12306
P407
P577
2015-03-10T00:00:00Z